Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Addiction pharmacotherapy 2000: new options, new challenges.

R A Rawson1, M J McCann, A J Hasson

  • 1UCLA Integrated Substance Abuse Programs, Los Angeles, California 90025, USA.

Journal of Psychoactive Drugs
|February 24, 2001
PubMed
Summary

Advances in addiction pharmacotherapy are improving substance abuse treatment. New medications for alcoholism and opiate dependence offer better access and effectiveness, with ongoing research for stimulant addiction treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of ferritin heavy chain on oxidative stress, cell proliferation and apoptosis in geese follicular granulosa cells.

British poultry science·2024
Same author

Down-regulation of long non-coding RNA DUXAP8 suppresses proliferation, metastasis and EMT by modulating miR-498 through TRIM44-mediated AKT/mTOR pathway in non-small-cell lung cancer.

European review for medical and pharmacological sciences·2020
Same author

Associations of serum magnesium levels and calcium-magnesium ratios with mortality in patients with coronary artery disease.

Diabetes & metabolism·2019
Same author

Circulating retinol-binding protein 4 is associated with the development and regression of non-alcoholic fatty liver disease.

Diabetes & metabolism·2019
Same author

A polymorphism in the OPRM1 3'-untranslated region is associated with methadone efficacy in treating opioid dependence.

The pharmacogenomics journal·2016
Same author

Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users.

Molecular psychiatry·2016

Area of Science:

  • Pharmacology
  • Addiction Medicine
  • Neuroscience

Background:

  • Substance abuse research and treatment integration is advancing.
  • Pharmacotherapy plays a crucial role in this evolution.
  • Current treatments are expanding for various substance use disorders.

Purpose of the Study:

  • To highlight the impact of pharmacotherapy advancements on substance abuse treatment.
  • To discuss the current and emerging medication options for alcoholism, opiate dependence, and stimulant addiction.
  • To emphasize the importance of integrating new treatments into standard care.

Main Methods:

  • Review of current pharmacotherapies for substance abuse.
  • Discussion of newly approved and developing medications.

Related Experiment Videos

  • Analysis of the potential impact of these advancements on patient access and treatment effectiveness.

    • Main Results:

    • Alcoholism treatment now includes disulfiram, naltrexone, and soon acamprosate.
    • Opiate dependence treatment has expanded with LAAM and anticipated buprenorphine/naloxone availability outside traditional settings.
    • Research is actively pursuing medications for stimulant addiction, including cocaine and methamphetamine.

    Conclusions:

    • Pharmacotherapy advancements are significantly improving substance abuse treatment options.
    • The integration of new medications promises enhanced access and effectiveness of care.
    • Continued research and adoption of these treatments are vital for patient recovery.